Sidonia Fagarasan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sidonia Fagarasan has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Keiichiro Suzuki
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan
5 shared publicationsBaihao Zhang
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan; Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan
4 shared publicationsKazuhiro Sonomura
Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto, Japan
4 shared publicationsAlexis Vogelzang
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan
3 shared publications- Alexis Vogelzang
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan
3 shared publications - Baihao Zhang
Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan
3 shared publications
Latest Publications
- 13 April 2026
- Published by Springer Nature in Nature Immunology
Purine salvage pathway protects CD8+ T cells from metabolic stress
Metabolic stress from a high-fat diet (HFD) impairs antitumor immunity through persistent metabolic rewiring, but its effects and long-term impact on CD8+ T cell metabolism remain unknown. Here, we found that even temporary exposure to a HFD impaired antitumor immunity 10 weeks after reversion to a normal diet. This was due to lasting metabolome changes that included enrichment in phospholipids sensitive to peroxidation and depletion of antioxidants, affecting the survival and function of CD8+ T cells. Under oxidative stress, CD8+ T cells utilized the xanthine salvage pathway to produce guanosine triphosphate, enhancing the amount of tetrahydrobiopterin. Xanthine supplementation reduced lipid peroxidation in tumor-draining lymph nodes and improved antitumor immunity in mice previously on a HFD. Our data indicate that metabolic stress in CD8+ T cells persists long after restoration of a balanced diet, and manifests as vulnerability to ferroptosis, which could be mitigated by replenishing biopterins through the xanthine salvage pathway.
- 13 April 2026
- Published by Springer Nature in Nature Immunology
Purine salvage pathway protects CD8+ T cells from metabolic stress
Metabolic stress from a high-fat diet (HFD) impairs antitumor immunity through persistent metabolic rewiring, but its effects and long-term impact on CD8+ T cell metabolism remain unknown. Here, we found that even temporary exposure to a HFD impaired antitumor immunity 10 weeks after reversion to a normal diet. This was due to lasting metabolome changes that included enrichment in phospholipids sensitive to peroxidation and depletion of antioxidants, affecting the survival and function of CD8+ T cells. Under oxidative stress, CD8+ T cells utilized the xanthine salvage pathway to produce guanosine triphosphate, enhancing the amount of tetrahydrobiopterin. Xanthine supplementation reduced lipid peroxidation in tumor-draining lymph nodes and improved antitumor immunity in mice previously on a HFD. Our data indicate that metabolic stress in CD8+ T cells persists long after restoration of a balanced diet, and manifests as vulnerability to ferroptosis, which could be mitigated by replenishing biopterins through the xanthine salvage pathway.
- Open Access
- 29 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Cell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems
Despite its broad application in in vitro studies, the application of targeted protein degradation (TPD) to animal models faces considerable challenges. Here, we develop inducible and cell-type specific TPD systems in mice using two degron systems: Oryza sativa TIR1F74G (OsTIR1)-auxin-inducible degron 2 (AID2) and human cereblon (hCRBN)-SALL4 degron (S4D). Efficient degradation of Satb1Venus protein by these systems recapitulates phenotypes observed in the Satb1-deficient mice. These TPD are successfully applied in both the fetal and neonatal stages. The OsTIR1-AID2 system proves to be effective for membrane proteins such as PD-1, emulating the effects of the anti-PD-1 antibody. Degradation of Bcl11b reveals a role of Bcl11b which was not characterized by the Cre-loxP system. Collectively, in vivo TPD technologies developed in this study enable inducible, temporal, and cell type-specific depletion of target proteins with high efficacy in mice. These technologies have a wide range of applications in the diverse fields of biological and medical research.
- 29 November 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessCell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems
Despite its broad application in in vitro studies, the application of targeted protein degradation (TPD) to animal models faces considerable challenges. Here, we develop inducible and cell-type specific TPD systems in mice using two degron systems: Oryza sativa TIR1F74G (OsTIR1)-auxin-inducible degron 2 (AID2) and human cereblon (hCRBN)-SALL4 degron (S4D). Efficient degradation of Satb1Venus protein by these systems recapitulates phenotypes observed in the Satb1-deficient mice. These TPD are successfully applied in both the fetal and neonatal stages. The OsTIR1-AID2 system proves to be effective for membrane proteins such as PD-1, emulating the effects of the anti-PD-1 antibody. Degradation of Bcl11b reveals a role of Bcl11b which was not characterized by the Cre-loxP system. Collectively, in vivo TPD technologies developed in this study enable inducible, temporal, and cell type-specific depletion of target proteins with high efficacy in mice. These technologies have a wide range of applications in the diverse fields of biological and medical research.
- 27 November 2024
- Published by Elsevier in Trends in Immunology
- Vol. 45 (12) , 928-930
Breaking down IgA: Tomasiella immunophila enlightens microbiome–immune interactions
- 27 November 2024
- Published by Elsevier in Trends in Immunology
- Vol. 45 (12) , 928-930
Breaking down IgA: Tomasiella immunophila enlightens microbiome–immune interactions
- 16 September 2023
- Published by Elsevier in Trends in Cell Biology
- Vol. 34 (5) , 363-370
Spermidine – an old molecule with a new age-defying immune function
- 16 September 2023
- Published by Elsevier in Trends in Cell Biology
- Vol. 34 (5) , 363-370
Spermidine – an old molecule with a new age-defying immune function
- 5 November 2022
- Published by Elsevier in Trends in Immunology
- Vol. 43 (12) , 990-1005
Secreted immune metabolites that mediate immune cell communication and function
- 5 November 2022
- Published by Elsevier in Trends in Immunology
- Vol. 43 (12) , 990-1005
Secreted immune metabolites that mediate immune cell communication and function
- Top Cited Papers
- 28 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6618) , 370-+
Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice
Spermidine (SPD) delays age-related pathologies in various organisms. SPD supplementation overcame the impaired immunotherapy against tumors in aged mice by increasing mitochondrial function and activating CD8 + T cells. Treatment of naïve CD8 + T cells with SPD acutely enhanced fatty acid oxidation. SPD conjugated to beads bound to the mitochondrial trifunctional protein (MTP). In the MTP complex, synthesized and purified from Escherichia coli , SPD bound to the α and β subunits of MTP with strong affinity and allosterically enhanced their enzymatic activities. T cell–specific deletion of the MTP α subunit abolished enhancement of programmed cell death protein 1 (PD-1) blockade immunotherapy by SPD, indicating that MTP is required for SPD-dependent T cell activation.
- 28 October 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6618) , 370-+
Top Cited PapersSpermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice
Spermidine (SPD) delays age-related pathologies in various organisms. SPD supplementation overcame the impaired immunotherapy against tumors in aged mice by increasing mitochondrial function and activating CD8 + T cells. Treatment of naïve CD8 + T cells with SPD acutely enhanced fatty acid oxidation. SPD conjugated to beads bound to the mitochondrial trifunctional protein (MTP). In the MTP complex, synthesized and purified from Escherichia coli , SPD bound to the α and β subunits of MTP with strong affinity and allosterically enhanced their enzymatic activities. T cell–specific deletion of the MTP α subunit abolished enhancement of programmed cell death protein 1 (PD-1) blockade immunotherapy by SPD, indicating that MTP is required for SPD-dependent T cell activation.
- Top Cited PapersOpen Access
- 3 November 2021
- Published by Springer Nature in Nature
- Vol. 599 (7885) , 471-476
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
Small, soluble metabolites not only are essential intermediates in intracellular biochemical processes, but can also influence neighbouring cells when released into the extracellular milieu1–3. Here we identify the metabolite and neurotransmitter GABA as a candidate signalling molecule synthesized and secreted by activated B cells and plasma cells. We show that B cell-derived GABA promotes monocyte differentiation into anti-inflammatory macrophages that secrete interleukin-10 and inhibit CD8+ T cell killer function. In mice, B cell deficiency or B cell-specific inactivation of the GABA-generating enzyme GAD67 enhances anti-tumour responses. Our study reveals that, in addition to cytokines and membrane proteins, small metabolites derived from B-lineage cells have immunoregulatory functions, which may be pharmaceutical targets allowing fine-tuning of immune responses.
- 3 November 2021
- Published by Springer Nature in Nature
- Vol. 599 (7885) , 471-476
Top Cited PapersOpen AccessB cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
Small, soluble metabolites not only are essential intermediates in intracellular biochemical processes, but can also influence neighbouring cells when released into the extracellular milieu1–3. Here we identify the metabolite and neurotransmitter GABA as a candidate signalling molecule synthesized and secreted by activated B cells and plasma cells. We show that B cell-derived GABA promotes monocyte differentiation into anti-inflammatory macrophages that secrete interleukin-10 and inhibit CD8+ T cell killer function. In mice, B cell deficiency or B cell-specific inactivation of the GABA-generating enzyme GAD67 enhances anti-tumour responses. Our study reveals that, in addition to cytokines and membrane proteins, small metabolites derived from B-lineage cells have immunoregulatory functions, which may be pharmaceutical targets allowing fine-tuning of immune responses.
- 1 October 2020
- Published by Elsevier in Current Opinion in Immunology
- Vol. 66, 82-89
Bacteria-immune cells dialog and the homeostasis of the systems
- 1 October 2020
- Published by Elsevier in Current Opinion in Immunology
- Vol. 66, 82-89
Bacteria-immune cells dialog and the homeostasis of the systems
- Open Access
- 9 September 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (38) , 23674-23683
Circulation of gut-preactivated naïve CD8+T cells enhances antitumor immunity in B cell-defective mice
Significance: Accumulating evidence supports important roles for the microbiota in health and disease. The absence of IgA induces microbial dysbiosis, leading to inflammation in the gut environment. Here, we found that the strong antitumor immunity of B cell-deficient mice is due to their microbial dysbiosis, leading to activation of type I interferon (IFN) signaling in peripheral CD8+T cells. The constant circulation of CD8+T cells, particularly the naïve subset between the periphery and the gut, leads to the induction of a gut-educated naïve subpopulation in the periphery. Exposure to type I IFN in the gut endows this naïve subpopulation with superior effector potential. These data provide important insights into how the gut environment can shape peripheral immunity.
- 9 September 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (38) , 23674-23683
Open AccessCirculation of gut-preactivated naïve CD8+T cells enhances antitumor immunity in B cell-defective mice
Significance: Accumulating evidence supports important roles for the microbiota in health and disease. The absence of IgA induces microbial dysbiosis, leading to inflammation in the gut environment. Here, we found that the strong antitumor immunity of B cell-deficient mice is due to their microbial dysbiosis, leading to activation of type I interferon (IFN) signaling in peripheral CD8+T cells. The constant circulation of CD8+T cells, particularly the naïve subset between the periphery and the gut, leads to the induction of a gut-educated naïve subpopulation in the periphery. Exposure to type I IFN in the gut endows this naïve subpopulation with superior effector potential. These data provide important insights into how the gut environment can shape peripheral immunity.